China Histology And Cytology Market Size & Outlook
Related Markets
China histology and cytology market highlights
- The China histology and cytology market generated a revenue of USD 1,185.5 million in 2024 and is expected to reach USD 3,037.6 million by 2030.
- The China market is expected to grow at a CAGR of 17% from 2025 to 2030.
- In terms of segment, cytology was the largest revenue generating type in 2024.
- Cytology is the most lucrative type segment registering the fastest growth during the forecast period.
Histology and cytology market data book summary
| Market revenue in 2024 | USD 1,185.5 million |
| Market revenue in 2030 | USD 3,037.6 million |
| Growth rate | 17% (CAGR from 2025 to 2030) |
| Largest segment | Cytology |
| Fastest growing segment | Cytology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Histology, Cytology |
| Key market players worldwide | Hologic Inc, BD, Abbott Laboratories, Merck KGaA, Roche Holding AG, Thermo Fisher Scientific Inc, Becton Dickinson & Co, Danaher Corp, Sysmex Corp, Koninklijke Philips NV |
Other key industry trends
- In terms of revenue, China accounted for 5.6% of the global histology and cytology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan histology and cytology market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,037.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Histology And Cytology Market Scope
Histology And Cytology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Sysmex Corp | View profile | 10448 | 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 | http://www.sysmex.co.jp |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Koninklijke Philips NV | View profile | 73712 | Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BC | https://www.philips.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
China histology and cytology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to histology and cytology market will help companies and investors design strategic landscapes.
Cytology was the largest segment with a revenue share of 72.01% in 2024. Horizon Databook has segmented the China histology and cytology market based on histology, cytology covering the revenue growth of each sub-segment from 2018 to 2030.
China is recognized to have approximately one fifth of the world’s population and considerable influence on global estimates of the present and future burden of various cancer. According IARC, the number of new cervical cancer cases in China in 2020 was 109,741. The country accounts for about 14% of annual cases of cervical cancer globally.
The first necessary step for successful cytology-based screening programs in China is to establish the necessary infrastructure to collect and transport smear samples to high-quality laboratories for processing and analysis. Public and private players are entering into partnerships to increase investments and develop infrastructure to ensure sustainable growth. In addition, the setup of national mortality surveillance systems is expected to streamline healthcare delivery in the region.
Presence of the Ministry of Health of China affiliated Center of Health Information and Statistics and Chinese Center for Disease Control and Prevention is expected to promote better healthcare delivery and control the burden of cancer in China.
Reasons to subscribe to China histology and cytology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China histology and cytology market databook
-
Our clientele includes a mix of histology and cytology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China histology and cytology market , including forecasts for subscribers. This country databook contains high-level insights into China histology and cytology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China histology and cytology market size, by type, 2018-2030 (US$M)
China Histology And Cytology Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
